Investment Firm Adds Nearly $4 Million in DYN Shares
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
An overview of the major forces behind stock index movements, with guidance on tracking catalysts and assessing risk.
21,624 articlesA major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
Insider stock moves can spark questions about a company's future. This guide breaks down what viasat's chief accounti...
The Stanford board sold HeartFlow shares for about $8.5 million, triggering questions about insider signals. This art...
When a CFO sells company shares worth millions, investors naturally wonder what it means for stock risk and future re...
When a CEO sells stock, investors listen. This article breaks down what the Electronic Arts CEO's roughly $1 million ...
Berkshire Hathaway made some notable portfolio shifts that surprised many investors. This guide explains what happene...
Want to grow your portfolio faster? This guide shows how to apply a stocks double right strategy with two momentum-fr...
When a downgrade hits a stock, it can spark more questions than answers. This article unpacks why phreesia stock cloc...
Stock splits can make a popular stock feel more approachable, but they don’t change the business. Read on to see how ...
Archer Aviation’s stock rally fizzled as the market shifted away from high-growth bets with unproven models. This art...
Quantum dreams meet market drama as Rigetti and peers grab headlines. This guide breaks down why rigetti computing st...
Lucid has wowed investors with fast-paced progress and bold promises. Yet the stock faces real headwinds. Here are th...